Show simple item record

dc.contributor.authorKaipatur, N.
dc.contributor.authorWu, Y.
dc.contributor.authorAdeeb, S.r
dc.contributor.authorStevenson, T.
dc.contributor.authorMajor, P.
dc.contributor.authorDoschak, Michael
dc.date.accessioned2017-01-30T11:40:35Z
dc.date.available2017-01-30T11:40:35Z
dc.date.created2013-10-10T20:00:31Z
dc.date.issued2013
dc.identifier.citationKaipatur, Neelambar R. and Wu, Yuchin and Adeeb, Samer and Stevenson, Thomas R. and Major, Paul W. and Doschak, Michael R. 2013. Impact of bisphosphonate drug burden in alveolar bone during orthodontic tooth movement in a rat model: A pilot study. American Journal of Orthodontics and Dentofacial Orthopedics. 144 (4): pp. 557-567.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/13963
dc.identifier.doi10.1016/j.ajodo.2013.06.015
dc.description.abstract

INTRODUCTION: The aim of this pilot study was to investigate the effect of long-term bisphosphonate drug use (bone burden) on orthodontic tooth movement in a rat model. METHODS: Sprague Dawley rats were used for orthodontic protraction of the maxillary first molars with nickel-titanium coil springs and temporary anchorage devices as anchorage. Four groups of 5 rats each were included in the study; the first 2 groups were dosed with alendronate or a vehicle during concurrent orthodontic tooth movement. The third and fourth groups were pretreated for 3 months with alendronate or vehicle injections, and bisphosphonate drug treatment was discontinued before orthodontic tooth movement. Tooth movement measurements were obtained at 0, 4, and 8 weeks using high-resolution in-vivo microcomputed tomography, and the tissues were analyzed with histology and dynamic labeling of bone turnover. RESULTS: Appreciable tooth movement was achieved during the 8-week duration of this study with nickel-titanium coil springs and temporary anchorage devices. Both bisphosphonate treatment groups exhibited reduced tooth movement compared with the vehicle-dosed controls with a tendency toward more severe reduction in the bisphosphonate predosed group. Concurrent dosing of the bisphosphonate drug resulted in 56% and 65% reductions in tooth protraction at the 4-week and 8-week times, respectively. The impact of bisphosphonate bone burden in retarding tooth movement was even greater, with 77% and 86% reductions in tooth movement at 4 and 8 weeks, respectively. CONCLUSIONS: In this study, we used a robust rat model of orthodontic tooth movement with temporary anchorage devices. It has provided evidence that the bone burden of previous bisphosphonate use will significantly inhibit orthodontic tooth movement.

dc.publisherMosby, Inc.
dc.titleImpact of bisphosphonate drug burden in alveolar bone during orthodontic tooth movement in a rat model: A pilot study
dc.typeJournal Article
dcterms.source.volume144
dcterms.source.number4
dcterms.source.startPage557
dcterms.source.endPage567
dcterms.source.issn0889-5406
dcterms.source.titleAmerican Journal of Orthodontics and Dentofacial Orthopedics
curtin.department
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record